NF-kappa B activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer.

R Ganapathi, M Tabata

Journal: Annals of the New York Academy of Sciences 2001;922():343-4

PMID: 11193918

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. [email protected]

DOI: 10.1111/j.1749-6632.2000.tb07060.x

Link outs

Free resources

Medical:

https://medlineplus.gov/lungcancer.html

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://onlinelibrary.wiley.com/resolve/openurl?ge...

MeSH Terms: Antineoplastic Agents, Phytogenic, Apoptosis, Camptothecin, Carcinoma, Non-Small-Cell Lung, DNA-Binding Proteins, Enzyme Inhibitors, Humans, I-kappa B Proteins, Irinotecan, Leupeptins, Lung Neoplasms, NF-KappaB Inhibitor alpha, NF-kappa B, Topoisomerase I Inhibitors, Transfection, Tumor Cells, Cultured